SCHEDULE: Vanguard Group Reports 0% Tandem Diabetes Stake
Beneficial Ownership Update
The Vanguard Group reports 0% beneficial ownership in Tandem Diabetes Care Inc. following an internal realignment.
Summary
- The Vanguard Group filed an Amendment No. 8 to Schedule 13G regarding its beneficial ownership in Tandem Diabetes Care Inc.
- As of March 13, 2026, The Vanguard Group reports 0% beneficial ownership of Tandem Diabetes Care Inc. Common Stock.
- This change is due to an internal realignment within The Vanguard Group, Inc. that became effective on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing. It reflects a change in The Vanguard Group's internal reporting structure, not a change in investment thesis or performance for Tandem Diabetes Care Inc.
Risks
- Investors tracking The Vanguard Group's aggregate holdings will need to consult disaggregated reports from its subsidiaries and business divisions to understand the full scope of Vanguard's investment in Tandem Diabetes Care Inc. post-realignment.
Future Outlook
No forward-looking statements or guidance regarding Tandem Diabetes Care Inc. are provided in this administrative filing.
Industry Context
StockSavvy.ai notes that this administrative change by The Vanguard Group reflects a broader trend among large asset managers to disaggregate reporting for compliance and internal management purposes. This shift impacts how institutional ownership is tracked by the market but does not necessarily indicate a change in investment strategy regarding Tandem Diabetes Care Inc. by Vanguard's underlying funds, only a change in the reporting structure of those holdings.
Stakeholder Impact
- Shareholders of Tandem Diabetes Care Inc. may observe a change in reported institutional ownership data from The Vanguard Group, but this is a reporting change and does not reflect a divestment of underlying holdings by Vanguard's managed funds.
Next Steps
- The Vanguard Group's subsidiaries or business divisions will now report their beneficial ownership in Tandem Diabetes Care Inc. separately, in reliance on SEC Release No. 34-39538.
Key Dates
| Date | Description |
|---|---|
| 01/12/2026 | Effective date of The Vanguard Group, Inc.'s internal realignment, leading to disaggregated reporting. |
| 03/13/2026 | Date of event requiring the filing of this statement, reflecting The Vanguard Group's 0% beneficial ownership. |
| 03/27/2026 | Date the Schedule 13G/A was signed by The Vanguard Group. |
Keywords
Vanguard Group, Tandem Diabetes Care, Schedule 13G, Beneficial Ownership, Institutional Ownership, Internal Realignment, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.